We buy, back, and build science-based health businesses – partnering with founders whether they’re ready to exit, to raise, or simply to grow.
EBITDA
$300K – $3M
Revenue
$1M+
South Florida
Southeast U.S. *US-wide for asset-light, telemedicine-enabled, or product models
Longevity, Diagnostics, Performance
Acquisition · Growth Equity · Operating Partnership
Strategic Minority Investment
Clear room to improve through technology, marketing, or expansion.